Changes induced by i.v. and subcutaneous teprotide in plasma renin, angiotensin I, angiotensin II, aldosterone and bradykinin were studied in a renal transplant patient with severe high renin hypertension, before and after trinephrectomy. The immediate reduction in BP produced by teprotide was not solely attributable to the inhibition of conversion of angiotensin I to angiotensin II, because there was also a transient increase in serum bradykinin; however, the prolonged antihypertensive effect of teprotide appeared independent of bradykinin. After trinephrectomy, teprotide lowered systolic BP but had no significant effect on diastolic BP or plasma bradykinin. ,-blockade prevented the secondary increase in plasma renin which followed teprotide, thereby potentiating its anti-hypertensive effect.
Introduction
Angiotensin I converting enzyme (ACE), a peptidylpeptide hydrolase also known as kininase II, converts angiotensin I (AI) to angiotensin II (All) and degrades bradykinin (Yang, Erdos and Levin, 1971) . Inhibition of these actions might be expected to reduce BP. The success has been reported of i.v. and subcutaneous teprotide, a parenteral ACE inhibitor, in reducing BP for 4 months in a woman who developed severe high renin hypertension after renal transplantation (VandenBurg et al., 1978) . The authors now report changes in plasma renin, AI, All, aldosterone and bradykinin concentrations produced by teprotide in the same patient, the effect of adding oxprenolol, and the results of i.v. teprotide after trinephrectomy (removal of the transplanted kidney as well as the patient's own kidneys).
Method
The patient has been described previously (VandenBurg et al., 1978) . Drugs were stopped 18 hr before each study except for frusemide, which was continued in a daily oral dose of 500 mg until trinephrectomy. The experiments were conducted after BP had become stable during run-in periods lasting one hr or more. Blood pressure measurements were made in the supine position, using an automatic recorder (arteriosonde Roche). Blood samples were drawn from a cannula inserted into a median cubital vein one hr before teprotide injection. Withdrawn blood was replaced by an equal volume of isotonic saline.
Plasma renin, AI, AII and aldosterone concentrations were measured by radio-immunoassay (Morton et al., 1976; Fraser, Guest and Young, 1973) . Plasma bradykinin was assayed by a previously described modification of the method of Talamo, Hamer and Acroton (1969) (Fig. 2) BP fell within 5 min of the i.v. injection of teprotide (0-5 mg/kg) and was still normal after 4 hr. A marked decrease in AII, and an increase in AI, were noted from the time of the first post-injection measurement (10 min) to that of the last measurement (4hr). Plasma aldosterone fell more slowly than All. Plasma bradykinin was well above preinjection levels at 10-30 min, but had returned to pre-injection levels at 2 hr. Study 3 (Fig. 3) Following the subcutaneous injection of 0-5 mg teprotide, BP did not change for over 2 hr, although AII and aldosterone concentrations had fallen and renin and AI had increased by this time. By 3-5 hr, there was a marked reduction in BP without further change in AII or aldosterone. The changes in these hormones were still present at 9 hr, although BP had risen towards pre-injection levels. Study 4 (Fig. 4) The rapid fall in BP produced by teprotide 0-5 mg/kg i.v. was not increased by a subsequent injection of 1 mg/kg; however, a further fall occurred within 40 min of a 160 mg oral dose of oxprenolol. This potentiation was associated with temporary reversal of the teprotide-induced hyperreninaemia. Vinci et al. (1979) found no effect on plasma bradykinin in 13 salt-replete and deplete hypertensive patients, although they did find increased urinary kinin excretion which was greatest in those with the largest decrements in BP. This suggested the possibility of an effect mediated through an increase in local tissue levels of bradykinin. Miller et al. (1975) were unable to demonstrate any influence on bradykinin concentrations in one-kidney Goldblatt dogs although Nasjiletti, Colina-Chourio and McGiff (1975) showed an effect. Johnston et al. (1979) It is uncertain why teprotide-induced changes in plasma AI and AII were more prolonged than the alterations in plasma bradykinin, although the enzyme which is inhibited is the same. It might be due to the greater affinity of ACE for bradykinin than for angiotensin I (Sofflar, 1976) or to the destruction of bradykinin by other proteases such as kininase I (Vinci et al., 1979) . Increased degradation of bradykinin through other metabolic pathways (Erdos, 1975) Although trinephrectomy abolished the effect of teprotide on diastolic BP, the authors were surprised to find a significant fall in systolic BP within 10-30 min which persisted for at least 4 hr. Man in 'T Veld et al. (1980) has described the production of orthostatic hypotension by captopril in fluiddepleted anephric haemodialysis patients, the effect being abolished by fluid repletion. Leslie et al. (1980) were unable to demonstrate any fall in BP in anephric patients given captopril 24 hr after haemodialysis.
The effect of the 3-blocker oxprenolol in reducing teprotide-induced hyperreninaemia and increasing its hypotensive effect should be noted. The combination of a converting enzyme inhibitor and a 3-blocker may be particularly potent.
